Zebrafish: A Relevant Genetic Model for Human Primary Immunodeficiency (PID) Disorders?

被引:2
|
作者
Basheer, Faiza [1 ,2 ]
Sertori, Robert [1 ]
Liongue, Clifford [1 ,2 ]
Ward, Alister C. [1 ,2 ]
机构
[1] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia
[2] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat IMPACT, Geelong, Vic 3216, Australia
关键词
immunity; immunodeficiency; zebrafish; T-CELL DEVELOPMENT; HEMATOPOIETIC STEM; LYMPHOCYTE DEVELOPMENT; NEUTROPHIL MOTILITY; IMMUNE-DEFICIENCY; ADULT ZEBRAFISH; MUTANT; MACROPHAGES; MUTATIONS; XENOGRAFT;
D O I
10.3390/ijms24076468
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Primary immunodeficiency (PID) disorders, also commonly referred to as inborn errors of immunity, are a heterogenous group of human genetic diseases characterized by defects in immune cell development and/or function. Since these disorders are generally uncommon and occur on a variable background profile of potential genetic and environmental modifiers, animal models are critical to provide mechanistic insights as well as to create platforms to underpin therapeutic development. This review aims to review the relevance of zebrafish as an alternative genetic model for PIDs. It provides an overview of the conservation of the zebrafish immune system and details specific examples of zebrafish models for a multitude of specific human PIDs across a range of distinct categories, including severe combined immunodeficiency (SCID), combined immunodeficiency (CID), multi-system immunodeficiency, autoinflammatory disorders, neutropenia and defects in leucocyte mobility and respiratory burst. It also describes some of the diverse applications of these models, particularly in the fields of microbiology, immunology, regenerative biology and oncology.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Application of zebrafish oculomotor behavior to model human disorders
    Maurer, Colette M.
    Huang, Ying-Yu
    Neuhauss, Stephan C. F.
    REVIEWS IN THE NEUROSCIENCES, 2011, 22 (01) : 5 - 16
  • [32] Immune Globulin Subcutaneous (Human) 20% In Primary Immunodeficiency Disorders
    McCormack, Paul L.
    DRUGS, 2012, 72 (08) : 1087 - 1097
  • [33] Immune Globulin Subcutaneous (Human) 20%In Primary Immunodeficiency Disorders
    Paul L. McCormack
    Drugs, 2012, 72 : 1087 - 1097
  • [34] PRIMARY AND ACQUIRED IMMUNODEFICIENCY DISORDERS
    GUPTA, S
    IMMUNOLOGY TODAY, 1986, 7 (11): : 324 - 325
  • [35] Autoimmunity and Primary Immunodeficiency Disorders
    Eric Allenspach
    Troy R. Torgerson
    Journal of Clinical Immunology, 2016, 36 : 57 - 67
  • [36] Autoimmunity and Primary Immunodeficiency Disorders
    Allenspach, Eric
    Torgerson, Troy R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 : S57 - S67
  • [37] Vaccination in Primary Immunodeficiency Disorders
    Sobh, Ali
    Bonilla, Francisco A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (06): : 1066 - 1075
  • [38] The skin in primary immunodeficiency disorders
    Smitt, JHS
    Wulffraat, NM
    Kuijpers, TW
    EUROPEAN JOURNAL OF DERMATOLOGY, 2005, 15 (06) : 425 - 432
  • [39] Primary Immunodeficiency Disorders Preface
    Montanaro, Anthony
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (04) : IX - X
  • [40] Primary Immunodeficiency Disorders Preface
    Kobrynski, Lisa J.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2019, 39 (01) : XI - XII